{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:44:06Z","timestamp":1793313846134,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001923","name":"DH | NIHR | Health Services Research Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Pussycat Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41590-021-01079-w","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T17:03:24Z","timestamp":1640192604000},"page":"109-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Identification of RIOK2 as a master regulator of human blood cell development"],"prefix":"10.1038","volume":"23","author":[{"given":"Shrestha","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8175-2957","authenticated-orcid":false,"given":"Mahesh","family":"Raundhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-4299","authenticated-orcid":false,"given":"Steven A.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7995-6202","authenticated-orcid":false,"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-3694","authenticated-orcid":false,"given":"Gregory A.","family":"Petsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4971-0404","authenticated-orcid":false,"given":"Laurie H.","family":"Glimcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"1079_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ageing\/afaa178","volume":"50","author":"L Palapar","year":"2021","unstructured":"Palapar, L. et al. Anaemia and physical and mental health in the very old: an individual participant data meta-analysis of four longitudinal studies of ageing. Age Ageing 50, 113\u2013119 (2021).","journal-title":"Age Ageing"},{"key":"1079_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79254-6","volume":"11","author":"MB Lopes","year":"2021","unstructured":"Lopes, M. B. et al. A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps. Sci. Rep. 11, 1784 (2021).","journal-title":"Sci. Rep."},{"key":"1079_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.leukres.2019.03.003","volume":"80","author":"K Becktell","year":"2019","unstructured":"Becktell, K. et al. Aplastic Anemia & MDS International Foundation: Bone Marrow Failure Disease Scientific Symposium 2018. Leuk. Res. 80, 19\u201325 (2019).","journal-title":"Leuk. Res."},{"key":"1079_CR4","doi-asserted-by":"crossref","unstructured":"Saygin, C. & Carraway, H. E. Current and emerging strategies for management of myelodysplastic syndromes. Blood Rev. 48, 100791 (2020).","DOI":"10.1016\/j.blre.2020.100791"},{"key":"1079_CR5","first-page":"30178","volume":"S1658-3876","author":"S Hong","year":"2020","unstructured":"Hong, S. et al. Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era. Hematol. Oncol. Stem Cell Ther. S1658-3876, 30178\u20133 (2020).","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"1079_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ajh.25950","volume":"95","author":"G Garcia-Manero","year":"2020","unstructured":"Garcia-Manero, G., Chien, K. S. & Montalban-Bravo, G. Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management. Am. J. Hematol. 95, 1399\u20131420 (2020).","journal-title":"Am. J. Hematol."},{"key":"1079_CR7","doi-asserted-by":"publisher","first-page":"106430","DOI":"10.1016\/j.leukres.2020.106430","volume":"97","author":"J Feld","year":"2020","unstructured":"Feld, J., Navada, S. C. & Silverman, L. R. Myelo-deception: luspatercept & TGF-beta ligand traps in myeloid diseases & anemia. Leuk. Res. 97, 106430 (2020).","journal-title":"Leuk. Res."},{"key":"1079_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1200\/JOP.2016.015214","volume":"12","author":"VR Bhatt","year":"2016","unstructured":"Bhatt, V. R. & Steensma, D. P. Hematopoietic cell transplantation for myelodysplastic syndromes. J. Oncol. Pract. 12, 786\u2013792 (2016).","journal-title":"J. Oncol. Pract."},{"key":"1079_CR9","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/nsmb.2403","volume":"19","author":"S Ferreira-Cerca","year":"2012","unstructured":"Ferreira-Cerca, S. et al. ATPase-dependent role of the atypical kinase Rio2 on the evolving pre-40S ribosomal subunit. Nat. Struct. Mol. Biol. 19, 1316\u20131323 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1079_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1083\/jcb.200904048","volume":"185","author":"I Zemp","year":"2009","unstructured":"Zemp, I. et al. Distinct cytoplasmic maturation steps of 40S ribosomal subunit precursors require hRio2. J. Cell Biol. 185, 1167\u20131180 (2009).","journal-title":"J. Cell Biol."},{"key":"1079_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-018-0193-0","volume":"558","author":"M Ameismeier","year":"2018","unstructured":"Ameismeier, M., Cheng, J., Berninghausen, O. & Beckmann, R. Visualizing late states of human 40S ribosomal subunit maturation. Nature 558, 249\u2013253 (2018).","journal-title":"Nature"},{"key":"1079_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41590-021-00895-4","volume":"22","author":"M Raundhal","year":"2021","unstructured":"Raundhal, M. et al. Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat. Immunol. 22, 520\u2013529 (2021).","journal-title":"Nat. Immunol."},{"key":"1079_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.12515","volume":"95","author":"A Pellagatti","year":"2015","unstructured":"Pellagatti, A. & Boultwood, J. The molecular pathogenesis of the myelodysplastic syndromes. Eur. J. Haematol. 95, 3\u201315 (2015).","journal-title":"Eur. J. Haematol."},{"key":"1079_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/leu.2010.31","volume":"24","author":"A Pellagatti","year":"2010","unstructured":"Pellagatti, A. et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia 24, 756\u2013764 (2010).","journal-title":"Leukemia"},{"key":"1079_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0092-8674(93)90456-Z","volume":"74","author":"RG Brennan","year":"1993","unstructured":"Brennan, R. G. The winged-helix DNA-binding motif: another helix-turn-helix takeoff. Cell 74, 773\u2013776 (1993).","journal-title":"Cell"},{"key":"1079_CR16","doi-asserted-by":"publisher","first-page":"37297","DOI":"10.1074\/jbc.R500013200","volume":"280","author":"N LaRonde-LeBlanc","year":"2005","unstructured":"LaRonde-LeBlanc, N. & Wlodawer, A. A family portrait of the RIO kinases. J. Biol. Chem. 280, 37297\u201337300 (2005).","journal-title":"J. Biol. Chem."},{"key":"1079_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4161\/trns.3.1.18917","volume":"3","author":"M Teichmann","year":"2012","unstructured":"Teichmann, M., Dumay-Odelot, H. & Fribourg, S. Structural and functional aspects of winged-helix domains at the core of transcription initiation complexes. Transcription 3, 2\u20137 (2012).","journal-title":"Transcription"},{"key":"1079_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/10428199409049629","volume":"13","author":"T Nakahata","year":"1994","unstructured":"Nakahata, T. & Okumura, N. Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers. Leuk. Lymphoma 13, 401\u2013409 (1994).","journal-title":"Leuk. Lymphoma"},{"key":"1079_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.stem.2017.07.015","volume":"21","author":"Z Tothova","year":"2017","unstructured":"Tothova, Z. et al. Multiplex CRISPR\u2013Cas9-based genome editing in human hematopoietic stem cells models clonal hematopoiesis and myeloid neoplasia. Cell Stem Cell 21, 547\u2013555 (2017).","journal-title":"Cell Stem Cell"},{"key":"1079_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2018.02.036","volume":"173","author":"RK Khajuria","year":"2018","unstructured":"Khajuria, R. K. et al. Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis. Cell 173, 90\u2013103 (2018).","journal-title":"Cell"},{"key":"1079_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/iub.2192","volume":"72","author":"L Gutierrez","year":"2020","unstructured":"Gutierrez, L., Caballero, N., Fernandez-Calleja, L., Karkoulia, E. & Strouboulis, J. Regulation of GATA1 levels in erythropoiesis. IUBMB Life 72, 89\u2013105 (2020).","journal-title":"IUBMB Life"},{"key":"1079_CR22","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1182\/blood-2007-09-115121","volume":"111","author":"L Gutierrez","year":"2008","unstructured":"Gutierrez, L. et al. Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis. Blood 111, 4375\u20134385 (2008).","journal-title":"Blood"},{"key":"1079_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1620\/tjem.242.83","volume":"242","author":"T Fujiwara","year":"2017","unstructured":"Fujiwara, T. GATA transcription factors: basic principles and related human disorders. Tohoku J. Exp. Med. 242, 83\u201391 (2017).","journal-title":"Tohoku J. Exp. Med."},{"key":"1079_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/iub.2177","volume":"72","author":"T Ling","year":"2020","unstructured":"Ling, T. & Crispino, J. D. GATA1 mutations in red cell disorders. IUBMB Life 72, 106\u2013118 (2020).","journal-title":"IUBMB Life"},{"key":"1079_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/MOH.0000000000000327","volume":"24","author":"MN Gnanapragasam","year":"2017","unstructured":"Gnanapragasam, M. N. & Bieker, J. J. Orchestration of late events in erythropoiesis by KLF1\/EKLF. Curr. Opin. Hematol. 24, 183\u2013190 (2017).","journal-title":"Curr. Opin. Hematol."},{"key":"1079_CR26","first-page":"137","volume":"211","author":"DE Zhang","year":"1996","unstructured":"Zhang, D. E. et al. Function of PU.1 (Spi-1), C\/EBP and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr. Top. Microbiol. Immunol. 211, 137\u2013147 (1996).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1079_CR27","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1158\/0008-5472.CAN-19-3167","volume":"80","author":"T Yokomizo-Nakano","year":"2020","unstructured":"Yokomizo-Nakano, T. et al. Overexpression of RUNX3 represses RUNX1 to drive transformation of myelodysplastic syndrome. Cancer Res. 80, 2523\u20132536 (2020).","journal-title":"Cancer Res."},{"key":"1079_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11010-020-03920-6","volume":"476","author":"S Daw","year":"2020","unstructured":"Daw, S. & Law, S. The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment. Mol. Cell. Biochem. 476, 535\u2013551 (2020).","journal-title":"Mol. Cell. Biochem."},{"key":"1079_CR29","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1101\/gad.12.15.2403","volume":"12","author":"C Nerlov","year":"1998","unstructured":"Nerlov, C. & Graf, T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12, 2403\u20132412 (1998).","journal-title":"Genes Dev."},{"key":"1079_CR30","doi-asserted-by":"publisher","first-page":"7460","DOI":"10.1128\/MCB.23.21.7460-7474.2003","volume":"23","author":"N Rekhtman","year":"2003","unstructured":"Rekhtman, N. et al. PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation. Mol. Cell. Biol. 23, 7460\u20137474 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"1079_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/iub.2188","volume":"72","author":"R Shimizu","year":"2020","unstructured":"Shimizu, R. & Yamamoto, M. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms. IUBMB Life 72, 142\u2013150 (2020).","journal-title":"IUBMB Life"},{"key":"1079_CR32","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1128\/MCB.00482-09","volume":"29","author":"Z Huang","year":"2009","unstructured":"Huang, Z. et al. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol. Cell. Biol. 29, 5168\u20135180 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"1079_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.femsre.2004.12.008","volume":"29","author":"L Aravind","year":"2005","unstructured":"Aravind, L., Anantharaman, V., Balaji, S., Babu, M. M. & Iyer, L. M. The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol. Rev. 29, 231\u2013262 (2005).","journal-title":"FEMS Microbiol. Rev."},{"key":"1079_CR34","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1182\/bloodadvances.2018025866","volume":"2","author":"X Zhong","year":"2018","unstructured":"Zhong, X. et al. HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes. Blood Adv. 2, 3137\u20133148 (2018).","journal-title":"Blood Adv."},{"key":"1079_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1101\/gad.1897310","volume":"24","author":"J Xu","year":"2010","unstructured":"Xu, J. et al. Transcriptional silencing of \u03b3-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 24, 783\u2013798 (2010).","journal-title":"Genes Dev."},{"key":"1079_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-539","volume":"15","author":"TW Chen","year":"2014","unstructured":"Chen, T. W. et al. ChIPseek, a web-based analysis tool for ChIP data. BMC Genomics 15, 539 (2014).","journal-title":"BMC Genomics"},{"key":"1079_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/prot.25252","volume":"85","author":"B Harish","year":"2017","unstructured":"Harish, B., Swapna, G. V., Kornhaber, G. J., Montelione, G. T. & Carey, J. Multiple helical conformations of the helix-turn-helix region revealed by NOE-restrained MD simulations of tryptophan aporepressor, TrpR. Proteins 85, 731\u2013740 (2017).","journal-title":"Proteins"},{"key":"1079_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molcel.2019.05.007","volume":"75","author":"X Bi","year":"2019","unstructured":"Bi, X. et al. RNA targets ribogenesis factor WDR43 to chromatin for transcription and pluripotency control. Mol. Cell 75, 102\u2013116 (2019).","journal-title":"Mol. Cell"},{"key":"1079_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/nyas.14092","volume":"1450","author":"CM Chaparro","year":"2019","unstructured":"Chaparro, C. M. & Suchdev, P. S. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann. N. Y. Acad. Sci. 1450, 15\u201331 (2019).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1079_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/14737140.2020.1770088","volume":"20","author":"J Feld","year":"2020","unstructured":"Feld, J., Belasen, A. & Navada, S. C. Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years. Expert Rev. Anticancer Ther. 20, 465\u2013482 (2020).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"1079_CR41","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/jnci\/91.19.1616","volume":"91","author":"JE Groopman","year":"1999","unstructured":"Groopman, J. E. & Itri, L. M. Chemotherapy-induced anemia in adults: incidence and treatment. J. Natl Cancer Inst. 91, 1616\u20131634 (1999).","journal-title":"J. Natl Cancer Inst."},{"key":"1079_CR42","doi-asserted-by":"publisher","unstructured":"Edginton-White, B. & Bonifer, C. The transcriptional regulation of normal and malignant blood cell development. FEBS J https:\/\/doi.org\/10.1111\/febs.15735 (2021).","DOI":"10.1111\/febs.15735"},{"key":"1079_CR43","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/gtc.12086","volume":"18","author":"M Suzuki","year":"2013","unstructured":"Suzuki, M. et al. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation. Genes Cells 18, 921\u2013933 (2013).","journal-title":"Genes Cells"},{"key":"1079_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s12185-014-1568-0","volume":"100","author":"T Moriguchi","year":"2014","unstructured":"Moriguchi, T. & Yamamoto, M. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation. Int. J. Hematol. 100, 417\u2013424 (2014).","journal-title":"Int. J. Hematol."},{"key":"1079_CR45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","volume":"100","author":"SJ Szabo","year":"2000","unstructured":"Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655\u2013669 (2000).","journal-title":"Cell"},{"key":"1079_CR46","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1182\/blood-2014-07-588806","volume":"124","author":"J Li","year":"2014","unstructured":"Li, J. et al. Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood 124, 3636\u20133645 (2014).","journal-title":"Blood"},{"key":"1079_CR47","doi-asserted-by":"publisher","first-page":"10716","DOI":"10.1073\/pnas.191362598","volume":"98","author":"DS Kaufman","year":"2001","unstructured":"Kaufman, D. S., Hanson, E. T., Lewis, R. L., Auerbach, R. & Thomson, J. A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 98, 10716\u201310721 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1079_CR48","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1074\/mcp.RA118.001259","volume":"18","author":"SA Myers","year":"2019","unstructured":"Myers, S. A. et al. Streamlined protocol for deep proteomic profiling of FAC-sorted cells and its application to freshly isolated murine immune cells. Mol. Cell Proteomics 18, 995\u20131009 (2019).","journal-title":"Mol. Cell Proteomics"},{"key":"1079_CR49","doi-asserted-by":"publisher","first-page":"190037","DOI":"10.1098\/rsob.190037","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang, J., Varin, T., Vieth, M. & Elkins, J. M. Crystal structure of human RIOK2 bound to a specific inhibitor. Open Biol. 9, 190037 (2019).","journal-title":"Open Biol."},{"key":"1079_CR50","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.1021\/bi0009284","volume":"39","author":"CS Chen","year":"2000","unstructured":"Chen, C. S., White, A., Love, J., Murphy, J. R. & Ringe, D. Methyl groups of thymine bases are important for nucleic acid recognition by DtxR. Biochemistry 39, 10397\u201310407 (2000).","journal-title":"Biochemistry"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01079-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T19:37:52Z","timestamp":1699990672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01079-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1038\/s41590-021-01079-w","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,22]]},"assertion":[{"value":"9 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.H.G. is a former Director of Bristol-Myers Squibb and the Waters Corporation and currently serves on the Board of Directors of GlaxoSmithKline Pharmaceuticals and Analog Devices and on the scientific advisory boards of Repare Therapeutics, Abpro Therapeutics and Kaleido Therapeutics. G.A.P. is on the Scientific Advisory Boards of Amicus Therapeutics, MeiraGTx, Annovis Bio, Retromer Therapeutics and Proclara Biosciences and holds equity or stock options in Denali Therapeutics, MeiraGTx, Annovis Bio, Retromer Therapeutics and Proclara Biosciences, companies that are developing therapies for neurodegenerative diseases. M.R. is currently an employee at Jnana Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}